These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27060321)

  • 41. [Comparison of detection of trisomy 8 with fluorescence in situ hybridization and conventional karyotype analysis in myelodysplastic syndrome].
    Zhang ZB; Liu SH; Li J; Bo LJ; Cui HY; Liu XP; Nie YX; Qin S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):115-8. PubMed ID: 12513811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
    Mecucci C
    Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
    Kawankar N; Jijina F; Ghosh K; Vundinti BR
    Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
    Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
    Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical and experimental study of two cases of myelodysplastic syndromes with double isochromosome 20q- anomaly].
    Gong SL; Xue YQ; Wang JM; Han FL; Xu YQ; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):35-8. PubMed ID: 15946507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of -5/5q- chromosome abnormality in myelodysplastic syndromes by interphase fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):517-9. PubMed ID: 11769675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
    Panani AD; Pappa V
    In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Report of ten cases of hematologic malignancies with idic(20q-) and literature review].
    Han YS; Xue YQ; Li TY; Zhang J; Chen SN; Pan JL; Wu YF; Wang Y; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):17-20. PubMed ID: 21429395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
    Braulke F; Müller-Thomas C; Götze K; Platzbecker U; Germing U; Hofmann WK; Giagounidis AA; Lübbert M; Greenberg PL; Bennett JM; Solé F; Slovak ML; Ohyashiki K; Le Beau MM; Tüchler H; Pfeilstöcker M; Hildebrandt B; Aul C; Stauder R; Valent P; Fonatsch C; Bacher U; Trümper L; Haase D; Schanz J
    Genes Chromosomes Cancer; 2015 Dec; 54(12):809-17. PubMed ID: 26355708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.